Latest filing published 26 Jul 2023 for GreenLight Biosciences Holdings, PBC, €243k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Juan Andrey Zarur (chief executive) discloses dealings in GreenLight Biosciences Holdings, PBC to SEC (Form 4). The record holds 2 filings, for trades running from 2 February 2022 to 24 July 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 26 July 2023: a transaction of €243k, in GreenLight Biosciences Holdings, PBC. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations